Liabilities / Assets
25th percentile
Higher debt load relative to assets than 25% of similar nonprofits.
Foundation to Eradicate Duchenne Inc.
990 • Fiscal year 2012 • EIN 71-0874241
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.00x
Liabilities / Revenue
26th percentile
Higher debt load relative to revenue than 26% of similar nonprofits.
Net Margin
26th percentile
Higher net margin than 26% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
9th percentile
Faster asset growth than 9% of similar nonprofits.
Revenue Growth
73rd percentile
Faster revenue growth than 73% of similar nonprofits.
Balance Sheet
Assets
Down$228,413
Down $57,785 (-20%) from 2011
Net Assets
Down$228,186
Down $52,850 (-19%) from 2011
Liabilities
Down$227
Down $4,935 (-96%) from 2011
Revenue And Expenses
Revenue
Up$868,867
Up $139,637 (+19%) from 2011
Expenses
Up$923,325
Up $229,850 (+33%) from 2011
Net Income
Down-$54,458
Down $90,213 (-252%) from 2011
Historical Trend
Filing Detail Status
This 2012 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2012 to Dec 31, 2012
Mission and Program Overview
Mission
The organization's mission is to provide research grants to fund aggressive research into treatments for duchenne muscular dystrophy and to support the effort to treat, and ultimately cure, this disease.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2012 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $228,413
- Liabilities
- $227
- Net assets
- $228,186
- Revenue
- $868,867
- Expenses
- $923,325
- Net income
- -$54,458